Bani Tamraz, Ph.D. - Publications

Affiliations: 
Pharmaceutical Sciences and Pharmacogenomics University of California, San Francisco, San Francisco, CA 
Area:
Analysis of Complex Genetic Traits

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, et al. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrobial Agents and Chemotherapy. PMID 32631821 DOI: 10.1128/Aac.00177-20  0.315
2020 Ionova Y, Ashenhurst J, Zhan J, Nhan H, Kosinski C, Tamraz B, Chubb A. CYP2C19 allele frequencies in over 2.2 million direct-to-consumer genetics research participants and the potential implication for prescriptions in a large health system. Clinical and Translational Science. PMID 32506666 DOI: 10.1111/Cts.12830  0.389
2018 Tamraz B, Huang Y, French AL, Kassaye S, Anastos K, Nowicki MJ, Gange S, Gustafson DR, Bacchetti P, Greenblatt RM, Hysi PG, Aouizerat BE. A genome-wide association study identifies a candidate gene associated with atazanavir exposure measured in hair. Clinical Pharmacology and Therapeutics. PMID 29315502 DOI: 10.1002/Cpt.1014  0.344
2013 Tamraz B, Fukushima H, Wolfe AR, Kaspera R, Totah RA, Floyd JS, Ma B, Chu C, Marciante KD, Heckbert SR, Psaty BM, Kroetz DL, Kwok PY. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenetics and Genomics. 23: 355-64. PMID 23652407 DOI: 10.1097/Fpc.0B013E3283620C3B  0.526
2012 Floyd JS, Kaspera R, Marciante KD, Weiss NS, Heckbert SR, Lumley T, Wiggins KL, Tamraz B, Kwok PY, Totah RA, Psaty BM. A screening study of drug-drug interactions in cerivastatin users: An adverse effect of clopidogrel Clinical Pharmacology and Therapeutics. 91: 896-904. PMID 22419147 DOI: 10.1038/Clpt.2011.295  0.493
2011 Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, et al. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenetics and Genomics. 21: 280-8. PMID 21386754 DOI: 10.1097/Fpc.0B013E328343Dd7D  0.473
2010 Kaspera R, Naraharisetti SB, Tamraz B, Sahele T, Cheesman MJ, Kwok PY, Marciante K, Heckbert SR, Psaty BM, Totah RA. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenetics and Genomics. 20: 619-29. PMID 20739906 DOI: 10.1097/Fpc.0B013E32833Ecace  0.52
2009 Trivedi NN, Tamraz B, Chu C, Kwok PY, Caughey GH. Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. The Journal of Allergy and Clinical Immunology. 124: 1099-105.e1-4. PMID 19748655 DOI: 10.1016/J.Jaci.2009.07.026  0.499
2007 Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, Hu D, Tamraz B, Pawlikowska L, Wassel-Fyr C, Huntsman S, Waliszewska A, Rossin E, Li R, et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. American Journal of Human Genetics. 80: 716-26. PMID 17357077 DOI: 10.1086/513206  0.534
Show low-probability matches.